Literature DB >> 2835348

Histopathological and immunohistochemical studies on nickel sulfide-induced tumors in F344 rats.

N Sano1, M Shibata, K Izumi, H Otsuka.   

Abstract

Twenty-five tumors induced in F344 male rats were examined histologically and immunohistochemically using antibodies against myoglobin, myosin, desmin and cathepsin B. Eight were from rats which had been given intramuscular (im) injection and 17 were from rats which had been given subcutaneous (sc) injection of 5 mg of Ni3S2. Among 10 rhabdomyosarcomas, myoglobin was detectable in 3, myosin in 8, and desmin in all, but cathepsin B was present in none. Out of 8 malignant fibrous histiocytomas, cathepsin B was detectable in all, but the other antigens were absent. In a leiomyosarcoma, only desmin was detected. In two fibrosarcomas, none of the markers were detected. In four undetermined tumors, one reacted only with anti-desmin antibody, two with only anti-cathepsin B antibody, and one with none of the antibodies. Of the three myogenic markers utilized in this study, anti-desmin antibody appeared to be the most sensitive. Cathepsin B was found mainly in the histiocytic cells of malignant fibrous histiocytoma. Thus, desmin appears to be particularly valuable in distinguishing immature myogenic tumors from other primitive tumors, while cathepsin B is useful in distinguishing malignant fibrous histiocytoma from other pleomorphic mesenchymal tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835348      PMCID: PMC5917459          DOI: 10.1111/j.1349-7006.1988.tb01579.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Localization of myoglobin in normal and neoplastic human skeletal muscle cells using an immunoperoxidase method.

Authors:  K Mukai; J Rosai; B E Hallaway
Journal:  Am J Surg Pathol       Date:  1979-08       Impact factor: 6.394

2.  Hindlimb muscle fiber populations of five mammals.

Authors:  M A Ariano; R B Armstrong; V R Edgerton
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

3.  Malignant fibrous histiocytoma.

Authors:  Y Konishi; Y Mii; H Maruyama; K Masuhara
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

4.  Myosin polymorphism in human skeletal muscles.

Authors:  L D Libera; A Margreth; I Mussini; C Cerri; G Scarlato
Journal:  Muscle Nerve       Date:  1978 Jul-Aug       Impact factor: 3.217

Review 5.  Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors.

Authors:  M Miettinen; V P Lehto; I Virtanen
Journal:  Ultrastruct Pathol       Date:  1984       Impact factor: 1.094

6.  Metal carcinogenesis. II. A study on the carcinogenic activity of cobalt, copper, iron, and nickel compounds.

Authors:  J P GILMAN
Journal:  Cancer Res       Date:  1962-02       Impact factor: 12.701

7.  Diagnosis of human childhood rhabdomyosarcoma of antibodies to desmin, the structural protein of muscle specific intermediate filaments.

Authors:  M Altmannsberger; M Osborn; J Treuner; A Hölscher; K Weber; A Shauer
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1982

8.  Radioimmunoassay for human myoglobin: methods and results in patients with skeletal muscle or myocardial disorders.

Authors:  K Miyoshi; S Saito; H Kawai; A Kondo; M Iwasa; T Hayashi; M Yagita
Journal:  J Lab Clin Med       Date:  1978-09

9.  Ultrastructural study of Ni3S2-induced tumors in rats.

Authors:  S Yamashiro; P K Basrur; J P Gilman; T J Hulland; Y Fujimoto
Journal:  Acta Pathol Jpn       Date:  1983-01

10.  Desmin is a specific marker for rhabdomyosarcomas of human and rat origin.

Authors:  M Altmannsberger; K Weber; R Droste; M Osborn
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

View more
  2 in total

1.  Biological tolerance of different materials in bulk and nanoparticulate form in a rat model: sarcoma development by nanoparticles.

Authors:  Torsten Hansen; Gaëlle Clermont; Antonio Alves; Rosy Eloy; Christoph Brochhausen; Jean Pierre Boutrand; Antonietta M Gatti; C James Kirkpatrick
Journal:  J R Soc Interface       Date:  2006-12-22       Impact factor: 4.118

2.  Nano-hole induction by nanodiamond and nanoplatinum liquid, DPV576, reverses multidrug resistance in human myeloid leukemia (HL60/AR).

Authors:  Alia Ghoneum; Shivani Sharma; James Gimzewski
Journal:  Int J Nanomedicine       Date:  2013-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.